Radiomics and artificial intelligence (AI) may increase the differentiation of benign from malignant kidney lesions, differentiation of angiomyolipoma (AML) from renal cell carcinoma (RCC), differentiation of oncocytoma from RCC, differentiation of different subtypes of RCC, to predict Fuhrman grade, to predict gene mutation through molecular biomarkers and to predict treatment response in metastatic RCC undergoing immunotherapy. Neural networks analyze imaging data. Statistical, geometrical, textural features derived are giving quantitative data of contour, internal heterogeneity and gray zone features of lesions. A comprehensive literature review was performed, until July 2022. Studies investigating the diagnostic value of radiomics in differentiation of renal lesions, grade prediction, gene alterations, molecular biomarkers and ongoing clinical trials have been analyzed. The application of AI and radiomics could lead to improved sensitivity, specificity, accuracy in detecting and differentiating between renal lesions. Standardization of scanner protocols will improve preoperative differentiation between benign, low-risk cancers and clinically significant renal cancers and holds the premises to enhance the diagnostic ability of imaging tools to characterize renal lesions.
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review / Ferro, Matteo; Crocetto, Felice; Barone, Biagio; Del Giudice, Francesco; Maggi, Martina; Lucarelli, Giuseppe; Busetto, Gian Maria; Autorino, Riccardo; Marchioni, Michele; Cantiello, Francesco; Crocerossa, Fabio; Luzzago, Stefano; Piccinelli, Mattia; Mistretta, Francesco Alessandro; Tozzi, Marco; Schips, Luigi; Falagario, Ugo Giovanni; Veccia, Alessandro; Vartolomei, Mihai Dorin; Musi, Gennaro; de Cobelli, Ottavio; Montanari, Emanuele; Tătaru, Octavian Sabin. - In: THERAPEUTIC ADVANCES IN UROLOGY. - ISSN 1756-2872. - 15:(2023), p. 17562872231164803. [10.1177/17562872231164803]
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review
Ferro, Matteo;Del Giudice, Francesco;Maggi, Martina;Lucarelli, Giuseppe;Busetto, Gian Maria;Tozzi, Marco;Schips, Luigi;
2023
Abstract
Radiomics and artificial intelligence (AI) may increase the differentiation of benign from malignant kidney lesions, differentiation of angiomyolipoma (AML) from renal cell carcinoma (RCC), differentiation of oncocytoma from RCC, differentiation of different subtypes of RCC, to predict Fuhrman grade, to predict gene mutation through molecular biomarkers and to predict treatment response in metastatic RCC undergoing immunotherapy. Neural networks analyze imaging data. Statistical, geometrical, textural features derived are giving quantitative data of contour, internal heterogeneity and gray zone features of lesions. A comprehensive literature review was performed, until July 2022. Studies investigating the diagnostic value of radiomics in differentiation of renal lesions, grade prediction, gene alterations, molecular biomarkers and ongoing clinical trials have been analyzed. The application of AI and radiomics could lead to improved sensitivity, specificity, accuracy in detecting and differentiating between renal lesions. Standardization of scanner protocols will improve preoperative differentiation between benign, low-risk cancers and clinically significant renal cancers and holds the premises to enhance the diagnostic ability of imaging tools to characterize renal lesions.File | Dimensione | Formato | |
---|---|---|---|
10.1177_17562872231164803.pdf
accesso aperto
Note: Ferro_Artificial intelligence and radiomics_2023
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
858.67 kB
Formato
Adobe PDF
|
858.67 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.